Legend Biotech Corp (LEGN)
45.18
-1.19
(-2.57%)
USD |
NASDAQ |
May 17, 16:00
45.18
0.00 (0.00%)
After-Hours: 20:00
Legend Biotech Free Cash Flow: -263.24M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -263.24M |
| December 31, 2023 | -416.00M |
| September 30, 2023 | -370.77M |
| June 30, 2023 | -378.22M |
| March 31, 2023 | -288.36M |
| December 31, 2022 | -223.56M |
| September 30, 2022 | -237.28M |
| June 30, 2022 | -220.71M |
| March 31, 2022 | -295.77M |
| Date | Value |
|---|---|
| December 31, 2021 | -243.87M |
| September 30, 2021 | -225.09M |
| June 30, 2021 | -239.53M |
| March 31, 2021 | -234.28M |
| December 31, 2020 | -253.29M |
| September 30, 2020 | -300.24M |
| June 30, 2020 | -208.64M |
| March 31, 2020 | -144.34M |
| December 31, 2019 | -122.24M |
Free Cash Flow Range, Past 5 Years
-416.00M
Minimum
Dec 2023
-122.24M
Maximum
Dec 2019
-259.19M
Average
-241.70M
Median
Free Cash Flow Benchmarks
| Johnson & Johnson | 18.23B |
| Bristol-Myers Squibb Co | 12.51B |
| 2seventy bio Inc | -168.04M |
| Exelixis Inc | 185.10M |
| Alnylam Pharmaceuticals Inc | 127.82M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 15.52M |
| Cash from Investing (Quarterly) | -396.15M |
| Cash from Financing (Quarterly) | 0.831M |
| Free Cash Flow Per Share (Quarterly) | 0.0509 |
| Free Cash Flow to Equity (Quarterly) | 4.205M |
| Free Cash Flow to Firm (Quarterly) | 9.273M |
| Free Cash Flow Yield | -3.23% |